AOD 9604

Target Fat Metabolism Without Anabolic GH Activation

AOD 9604 is a synthetic peptide derived from a specific fragment (amino acids 177–191) of human growth hormone (hGH). It was developed to retain the fat-burning properties of growth hormone while avoiding effects on blood glucose regulation, IGF-1 signaling, or muscle growth pathways.

Due to this selective mechanism, AOD 9604 has become a compound of interest in research focused on weight management, metabolic health, and fat-loss signaling without the broader hormonal impact of full-length HGH.

Product features

• Modified HGH fragment (177–191) — studied for selective fat metabolism signaling.
• Lyophilized (freeze-dried) formulation — supports extended shelf life and stability.
• Sterile 3 mL glass vial — designed for research-grade compound integrity.
• Butyl rubber stopper — enables secure resealing for multi-access handling.
• ETO-sterilized & depyrogenated — finished with tamper-evident aluminum flip-top.

Key benefits (Research Highlights)

• Lipolysis activation — studied for stimulating breakdown of stored fat while inhibiting new fat formation.
• Metabolic regulation — supports energy utilization and fat-handling pathways without altering glucose balance.
• Weight management research — investigated for reducing fat accumulation, particularly in abdominal and visceral regions.
• Non-anabolic profile — does not promote muscle growth or anabolic signaling in research models.
• Cartilage & joint interest — preclinical studies suggest regenerative effects on cartilage and connective tissue.

Research reference: dosage ranges used in studies

Scientific literature evaluating AOD 9604 has explored defined exposure ranges and multi-week research cycles to assess fat metabolism, lipid signaling, and metabolic outcomes.

Studies commonly focus on sustained exposure over set durations to evaluate changes in adipose tissue handling without endocrine disruption. All referenced quantities are provided strictly for educational and informational context within controlled research environments.

These values do not represent usage instructions or recommendations.

Research reference: safety & tolerability observations

Across controlled research settings, AOD 9604 has demonstrated a favorable tolerability profile. Its non-anabolic and non-lipogenic nature has been highlighted in metabolic research models.

• No significant impact on blood glucose or IGF-1 signaling reported in studies
• Minimal endocrine disruption observed compared to full-length HGH
• Occasional mild localized tissue responses noted in peptide administration models

All safety-related information is derived from published research and observational findings and is presented solely for transparency within a scientific context.

Need help selecting a fat-loss focused compound? Our consultation service can help determine whether AOD 9604 aligns with your metabolic or weight-management research objectives.

Disclaimer: For research purposes only. Not intended for human consumption. Information provided is for educational reference and does not constitute medical advice.